FDA approves prognostic test for high-risk breast cancer

Article

The Food and Drug Administration recently approved the TOP2A (topoisomerase 2 alpha) FISH (fluorescent in situ hybridization) pharmDx (Dako Denmark A/S, Glostrup, Denmark), a new genetic test that can detect alterations in the TOP2A gene in breast cancer cells derived from removed tumors; alterations signal an increased likelihood of tumor recurrence and decreased long-term survival.

The Food and Drug Administration recently approved the TOP2A (topoisomerase 2 alpha) FISH (fluorescent in situ hybridization) pharmDx (Dako Denmark A/S, Glostrup, Denmark), a new genetic test that can detect alterations in the TOP2A gene in breast cancer cells derived from removed tumors; alterations signal an increased likelihood of tumor recurrence and decreased long-term survival.

The test, which has been studied in 767 women at 21 centers in Denmark, is suitable only for premenopausal women and those with characteristics, such as tumor size or lymph node involvement, that suggest a higher likelihood of tumor recurrence or decreased survival.

The hope is that the information gleaned from the test, combined with other clinical data and laboratory test results, will better guide health-care professionals and their patients in choosing the most appropriate therapeutic course.

Commentary by Victoria L. Green, MD, MBA, JD, Associate Professor, Department of Gynecology and Obstetrics, Emory University, Atlanta, GA.

Specific proteins such as TOP2A, may help predict patient response to certain anthracyclines. Additionally, TOP2A appears to correlate with HER2 overamplification (another predictive marker). That said, we must wait for further research on the clinical value of this test procedure. Although in one study there was 100% concordance between TOP2A and HER2 overamplification, other studies have shown a 20% lack of concordance.

Related Videos
Why doxycycline PEP lacks clinical data for STI prevention in women
The importance of nipocalimab’s FTD against FNAIT | Image Credit:  linkedin.com
Enhancing cervical cancer management with dual stain | Image Credit: linkedin.com
Fertility treatment challenges for Muslim women during fasting holidays | Image Credit: rmanetwork.com
Understanding the impact of STIs on young adults | Image Credit: providers.ucsd.edu.
CDC estimates of maternal mortality found overestimated | Image Credit: rwjms.rutgers.edu.
Study unveils maternal mortality tracking trends | Image Credit: obhg.com
How Harmonia Healthcare is revolutionizing hyperemesis gravidarum care | Image Credit: hyperemesis.org
Unveiling gender disparities in medicine | Image Credit:  findcare.ahn.org.
Exploring the intersection of heart health and women's health | Image Credit: cedars-sinai.org
© 2024 MJH Life Sciences

All rights reserved.